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The  object  of  this  investigation was to  study  the  cross  immu- 
nological relationship that exists between two closely related types of 
group B  hemolytic streptococci. 
Overlapping serological reactions have recently been shown by the 
work of many investigators to occur with somewhat more frequency 
than  was  formerly  supposed.  They have  been  observed  between 
both related and unrelated bacterial species since the early investiga- 
tions of Gruber and Durham and others (1), who studied particularly 
the Gram-negative bacilli.  Among the Gram-positive cocci, however, 
knowledge of such complicating immunological relationships is more 
recent, while chemical studies, necessary for a  true understanding of 
the  mechanism underlying  these  serological  reactions,  are  still  in 
the initial stages.  Since Avery's (2)  observations on the serological 
cross reactions of typical and atypical Type II pneumococci) reports 
have appeared which show that substances responsible for such cross 
reactions occur not only in bacteria but also in other natural sources 
widely separated generically.  A  few of the specific polysaccharides 
concerned have  been  analyzed  sufficiently  to  establish  a  chemical 
basis  for the  serological relationships,  although the inherent experi- 
mental  difficulties have more often caused investigators to  employ 
serological methods only and to infer a  chemical basis  by  analogy. 
Chemical studies of great importance and interest have been made in con- 
nection  with  cross reactions associated with  pneumococcus polysaccharides: 
i The atypical Type II pneumococci,  subgroups II A and II B, described by 
Avery, have since been given separate type numbers, namely, Types V and VI, 
respectively (3). 
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for example,  the  close relationship  between  the  type-specific polysaccharides of 
Pneumococcus Type II, and  Friedl~nder's  bacillus  type B,  which parallels  the 
serological  cross  relationships  (4),  and  the  similar  cross  relationship  between 
Types III and VIII pneumococci (5-7).  Goebel (8, 9) showed that the Type III 
pneumococcus capsular  polysaccharide is  built  up  of molecules  of glucose and 
glucuronic acid in a  ratio  of 1:1,  while  the  Type VIII pneumococcus polysac- 
charide is composed of the same substances in the ratio of 7: 2.  ~  He believes that 
the basis for the immunological crossing resides in the identity of the configura- 
tion  of  the  aldobionic  acid  nucleus  common  to  both  carbohydrates.  Heidel- 
berger, Kabat,  and Shrivastava  (10)  conclude, from quantitative  estimations of 
the homologous and cross reacting antibodies in antisera for Types III and VIII 
pneumococci,  that  it  is  too soon to attempt  to localize the  cross reaction  to a 
definite portion of the common configuration of these molecules. 
The  chemical and immunological relationship  of the  acetylated and  the  de- 
acetylated forms of Pneumococcus Type I  polysaccharide  (11)  was further  evi- 
dence of the nature of the chemical basis of cross reactions. 
Immunologically  interrelated  polysaccharides  have  also  been  found  from 
widely  divergent  sources:  the  blood  group  A  substance  of man  and  Pneumo- 
coccus Type I  polysaccharide (the acetylated  form only, although the failure of 
the  deacetylated  form to  cross react  was  not  due  to  the  acetyl radical  (12)); 
gum arabic  and  Types II and  III pneumococci  (13);  other plant  gums  which 
cross react with Pneumococcus Type II (14).  These gums contain uronic acid, 
indicating that glucuronic acid or a related substance is the common determinant 
group.  Less  complete data  indicate  a  serological relationship  between  Type I 
Pneumococcus and a mouse virulent strain of Escherichia coli, probably dependent 
upon  capsular  polysaccharides.  Similar  polysaccharides  existing  in  Bacillus 
proteus'X-19  and  Rickettsia  prowazeki  explain  the  Weil-Felix  reaction  in  the 
serum of patients with typhus fever (16). 
The  production  in  vitro  of  antigens  containing  known  chemical  structures 
has  thrown  considerable light  on these  cross reactions  among natural  antigens 
(14,  17-22) and, as a  result, it has been concluded that a  complex chemical sub- 
stance may induce more than one kind of antibody in the animal body, depending 
upon determinant factors such as the presence of different chemical radicals, the 
position of these radicals in reference to others, and the presence of highly polar 
groups; but the underlying mechanism is far from being completely understood. 
In still other recently recorded instances, a where bacterial  cross relationships 
2 Heidelberger,  Kabat, and Shrivastava  (10)  recently gave this ratio as about 
3:1. 
Other examples in which the serological relationships have been worked out, 
but  in which the  chemical information is  less  complete or lacking,  are  the fol- 
lowing.  (a)  Additional  subtypes  of  Pneumococcus  Type  II  (23).  (b)  The 
relationship  between  yeast  and  Pneumococcus Type  II  (24).  (c)  Cross  reac- 
tions of the polysaccharide of Type II Pneumococcus with antiserum  for  Pas- 
teurega  cuniccdicida  (25).  (d)  The relationship  of Bacterium aerogenes to Pneu- REBECCA  C.  LANCEFIELD  27 
involving Gram-positive cocci have been explained on the basis of related polysac- 
charides,  the analysis has been entirely serological  Of spedal interest in con- 
nection with the present communication is the report by Bliss  that the immun- 
ological  relationship  between  one  type of group  F  hemolytic streptococci and 
one of group  G  is  due  to  identical  type-specific substances,  probably polysac- 
charides  (29). 
Materials and Methods 
The present report, based chiefly  on immunological data,  concerns the cross 
reactions of two closely  related serological  types of group B  hemolytic strepto- 
cocci.  The indications are that their type specificity is determined by polysac- 
charides  (30).  Group  B  includes  the  strains  usually  responsible  for  bovine 
mastitis, and also certain strains of human origin which are not ordinarily patho- 
genic for man.  These microorganisms are designated by some authors as Strepto- 
coccus mastitidis or as S. agalactiae; Stableforth (35 a) calls them "Group I mastiffs 
streptococci."  Originally  most of  the group B  streptococci encountered in  this 
laboratory were shown to be included within three serological  types.  In the first 
series of strains studied, one somewhat atypical member of the so called Type I 
was found,  and it was doubtful whether this strain,  K  127, really belonged in 
this  type.  Finally,  in  spite  of  incomplete  cross  agglutination  and  precipitin 
reactions, it was assigned to Type I  on account of satisfactory cross protection 
.experiments in mice.  Later, however, other strains were found which  had the 
same peculiarities as K  127, and this necessitated further study to classify  these 
streptococci properly.  In Table I are listed the strains so far found which belong 
in these two related types.  The relative distribution as to origin is probably of 
no  significance,  since  a  fair sampling from the  different sources  in  which  they 
occur has not been attempted. 
Antisera  and  extracts  were  prepared  as  prevously  described  (30 b).  The 
specific methods for each experiment are given under the tables. 
Cross Reactions between Types I a and Ib 
Extracts  of  all  the  strains  which  reacted  in  antisera  for  Type  I 
(hereafter  called  Type  I a *)  and  in  antisera  for the  atypical  Type I 
mococcus Type II, and  Friedliinder's bacillus  type B  (26).  (e)  The  reactions 
between the species-specific polysaccharides of gonococci and meningococci  and 
antiserum for Type III Pneumococcus  (27).  (f)  The report of two strains  of 
S. riridans,  not identical serologically,  which reacted in antiserum for Pneumo- 
coccus Type XXIX  (28). 
4 Stableforth  (35 a)  has reported the  existence  of main types of S. agalactiae 
within which he distinguishes  subtypes by reciprocal agglutinin absorption tests. 
Some of these are related to the Types II and III, group B, previously described 
by us.  In view of uncertainty as to the exact relationship of types defined  by 
Stableforth (35 a) and by Stewart (35 c) to those described in this country (30 b), 
the nomenclature previously  used  by us  has  been retained  for  the present. 28  RELATED  TYPES  OF  GROUP  B  HEMOLYTIC  STREPTOCOCCI 
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(hereafter called Type Ib) still reacted in these antisera after the sera 
were absorbed with strains classified as Types II or III.  The example, 
given in  Table II,  column 2,  shows  the  cross precipitin reactions of 
the  unabsorbed  Type  Ia  serum  used  to  illustrate  this  point.  The 
cross reactions with  crude extracts of strains  belonging to Types II 
and III were due to the presence of the group-speclfic carbohydrate, 
C,  in  the  extracts,  and  the  corresponding  anti-C  precipitin  in  the 
serum.  Absorption  of the serum with  bacteria of Type II removed 
TABLE  II 
Precipitin Reactions to Show the Close Relationship between Types Ia and Ib 
Crude  extract from  bacteria  of 
Type I a 
"  Ib 
"  II 
"  III 
Type I  a antiserum 
Serum untreated 
+++ 
++± 
++± 
++a: 
Serum absorbed* with Type II 
bacteria 
++ 
++ 
In all Tables:  -  indicates a negative reaction. 
-b to -1- q- -b -{- indicate degrees of reaction. 
Only one dilution of the various extracts is tabulated, although in most experi- 
ments several dilutions  were employed. 
In all precipitin tests, the dilutions of extract tested were contained in a volume 
of 0.4 cc. to which 0.2 cc. of undiluted  serum  was  added.  The readings  were 
made first as ring-tests,  then after thorough mixing  and incubation at 37°C. for 
2 hours, and the final reading, recorded here, after refrigeration overnight at 4°C. 
* Two parts  of undiluted  serum  were  thoroughly mixed  with  one  part  of 
packed bacteria, previously killed by heating at 56°C. for 1 hour.  The mixture 
was incubated in a water bath at 37°C. for 30 minutes and centrifuged at once. 
The clear supernatant serum was used in the precipitin reaction. 
this group-specific antibody from the serum, as illustrated in column 
3.  Extracts  from  bacteria  of  both  Types Ia  and  Ib  continued  to 
react  in  serum  thus  absorbed.  Similar  results  were  obtained when 
a  Type III strain was  used as the absorbing agent,  or when a  Type 
Ib  antiserum  was  absorbed  and  tested  in  the  same  manner.  Such 
experiments suggested that Types Ia and Ib might be identical. 
Reciprocal A bsorption Experiments 
A bsorption of Precipitins.--That Types I a and I b were not identical 
was  demonstrated  by  reciprocal  absorption  experiments.  Antisera 30  RELATED  TYPES  OF  GROUP  B  HEMOLYTIC  STREPTOCOCCI 
for Types Ia and Ib, which untreated showed reciprocal cross precip- 
itin  and protection reactions,  lost all antibodies when absorbed with 
streptococci  homologous  to  the  respective  type  serum,  but,  on  the 
other hand,  lost only their ability to cross react when absorbed with 
a heterologous strain of the related type.  Table III shows the results 
of  precipitin  tests  with  antisera  treated  in  this  way.  The  same 
relationship  was made evident if the absorption was performed with 
TABLE III 
Precipitin  Reactions 
Reciprocal Absorption* Experiment  to Show That Types Ia and Ib Are Related but 
Not Identical 
tExtr~'t from  bacteria  o! 
Type Ia antiserum 
Serum absorbed 
with (homologous) 
Type Ia bacteria~ 
Serum untreated 
Type  I  a  ++++  --  ++'4- 
Type  I  b  +++  --  -- 
Type  Ib antiserum 
tExtract from bacteria of  Serum  absorbed 
with (heterologous) 
Type I a  bacteria~ 
Serum ab~rbed 
with (heterologous) 
Type  Ib  baeteria$ 
Serum untreated 
Type  I  a  +++  --  -- 
Type  I  b  +++-4-  ++-4-  -- 
Serum  absorbed 
with (homologous) 
Type  I  b  bacteria~ 
* See footnote to Table II. 
t These extracts  were partly purified chemically so  that  they were free of 
group-specific carbohydrate, C 
~: The same results were obtained  when the absorption  was carried out with 
the extracted and partially purified type-specific substances instead of the whole 
bacteria. 
extracted,  partially purified,  type-specific polysaccharides from these 
two  types of organisms.  These  results  were  confirmed  with  many 
different antisera. 
Cross  Protection  between  Types  Ia  and  Ib.--T}:fis  relationship  was 
also established by protection tests in mice, since in the final analysis 
the best proof of immunological  specificity is based upon protection 
conferred  on  animals,  by passively  immunizing  them  with  the  re- 
spective sera.  Reciprocal protection tests with an excess of antiserum REBECCA  C.  LANCEFIELD  31 
titrated  against  decreasing  amounts  of  culture  showed  equal  cross 
protection  (Table IV) with both strains.  The Type I a  strain,  O  90, 
TABLE  IV 
Reciprocal Passive Protection Tests in Mice,  Using an Excess of Unabsorbed  Anti- 
serum to Show the Cross Protection between Types Ia and Ib 
Type I a culture 
strain O 90 
10-a 
10-~ 
10  4 
10-~ 
10-* 
10-s 
10-2 
10-1 
No serum 
Virulence  controls 
0.5 cc. undiluted antiserum 
D  48 hrs. 
D  41  " 
D  41  " 
D  41  " 
D89  " 
D  25  " 
D  20  " 
D  17  " 
(Homologous) 
Type Ia 
(Heterologous) 
Type Ib 
Type Ib culture 
strain H  36 B 
10-6 
10-~ 
10-4 
10-3 
10-~ 
10-1 
No serum  0.5 cc. undiluted antiserum 
Virulence  controls  (Heterologous)  (Homologous) 
Type I a  Type I b 
S 
D  26 hrs. 
D  21  " 
D21  " 
D  21  " 
D  21  " 
In all tables,  S  indicates  survived, and D  indicates died within  the  number 
of hours or days stated. 
The  protection  tests  were  performed  as  follows:  Serial  dilutions  in  broth 
were made of a fresh 16 hour broth culture, so that the amount to be inoculated 
was contained in 0.5 cc.  These dilutions,  simultaneously with 0.5 cc. of undiluted 
serum,  were  injected intraperitoneaUy into white mice, 18 to 20 gm. in weight. 
A series of controls received culture and no serum.  Survivors were observed for 
2 weeks before they were discarded.  Blood agar plates were poured containing, 
respectively, 10  -8 cc.,  10  -~ cc., and 10  -8 cc. of culture, and colony counts were 
made to estimate the number of organisms injected. 
was somewhat more virulent  than  the  Type Ib  strain,  H  36  B,  but 
both  Type Ia  and  Ib  antisera protected mice against infection with 32  RELATED TYPES  OF  GROUP  B  HEMOLYTIC  STREPTOCOCCI 
TABLE  Va 
Reciprocal Passive Protection Tests in Mice, Using Varying Amounts of Absorbed and 
Unabsorbed Antiserum to Show That Types Ia and Ib Are Related but Not Identical 
Type  Ia  culture  (homolo- 
gous)  strain  O 90 
0.5 cc. 1:200 dil. 
44  (4  (4 
44  4t  4g 
(4  4t  4g 
4¢  (4  (g 
4#  4g  44  4( 
44  (4  44  44 
(4  44  (#  44 
~4  4¢  4(  (4 
4¢  ~4  (4  44 
44  4(  4(  (4 
(4  (4  4~  (4 
(4  44  4(  44 
(4  44  (4  ¢4 
44  4#  44  (4 
~4  (4  (4  44 
44  44  44  4g 
(¢  (4  ~4  (4 
44  44  4~  44 
0.5 cc. of serum 
diluted 
1:1 
~4 
4~ 
44 
~4 
1:2 
1:10 
1:50 
1:100 
1:250 
1:500 
1:1,000 
1:1,500 
1:2,000 
1:2,500 
1:3,000 
1:4,000 
1:5,000 
1:6,000 
1:7,000 
1:8,000 
1:9,000 
1:10,000 
Type  Is  antiserum  (against  strain  O  90) 
Serum  untreated 
S 
S 
S 
S 
S 
S 
S 
S 
S 
S 
S 
D 6 days 
S 
D 6 days 
S 
D 3 days 
S 
D 3 days 
D4  " 
Serum  absorbed 
with 
(homologous) 
*Type  Ia 
D 1 dayt 
D  1  " 
D  1  " 
D  1  " 
D  1  " 
D  1  " 
D  1  " 
SVirulence  control 
Nosemm  [  Dlday  ]  [ 
Serum  absorbed 
with 
(heterologous) 
Type Ib 
S 
S 
S 
S 
S 
S 
S 
S 
S 
D 3 days 
D 6  " 
S 
D 3 days 
S 
D 7days 
Protection tests recorded in Tables V  a,  b, c, and d were performed as follows: 
Serial dilutions of serum in saline, contained in a  volume of 0.5  cc., were in- 
jected intraperitoneally into white mice simultaneously with 0.5  cc.  of a  1:200 
broth dilution of a fresh 16 hour broth  culture.  Controls  received  this dilution 
of  culture  without  serum.  Additional  controls  which  received from  10 -I  cc. 
through  10 -s cc.  were included to determine the minimal lethal dose of the cul- 
ture.  The technique of this determination and of the estimation of the number 
of  organisms inoculated was that  described under Table IV. 
* Strains K  158 A and K  107 were used as typical Type Ia strains for absorp- 
ton on account of the great difficulty of sedimenting strain O 90 in the  centrifuge. 
t  Further  tests  with a  larger amount  of serum  (0.5  cc.  undiluted serum)  and 
serial dilutions of culture,  usually  to a  dilution containing  10 -7 or  10 -s cc., re- 
sulted in the death of all mice. 
Additional  virulence  controls  showed  that  10 -1  through  10 -s  cc.  of  this 
culture killed mice. REBECCA  C.  LANCEFIELD  33 
TABLE vb 
ReciprocaIPassi~Protec~onTestsinMice, UsingVa~ing Amoun~ ~Abs~be,  d and 
UnabsorbedAntiserumtoShowThatTyp~  IaandIbAreRelat~  b~ NotI~icat 
Type Ib culture (heterolo- 
gous) strain H36B 
0.5 cc. 1  : 200 dil. 
at  ta  ~t 
ac  ac  aa 
a*  a*  a~ 
~a  tg  ¢~ 
~t  at  at 
t,  tc  tg 
tc  ¢t  at 
c~  ,t  a¢ 
at  tc  tt 
tc  ta  tt 
at  tg  tg 
tc  tt  cc 
~  t,  tc 
at  ac  tt 
0.5 cc. of serum 
diluted 
1:1 
c, 
lc 
lc 
1:2 
I:I0 
1:50 
i:I00 
1:250 
1:500 
I:i,000 
I:I,500 
1:2,000 
1:2,500 
1:3,000 
1:4,000 
1:5,000 
1:6,000 
1:7,000 
1:8,000 
1:9,000 
1:10,000 
Type Ia antiserum (against strain O 90) 
Serum untreated 
S 
S 
S 
S 
S 
S 
S 
S 
S 
S 
S 
S 
S 
D 1 day 
S 
S 
S 
D lday 
D 1  " 
Serum absorbed 
with 
(homologous) 
*Type I a 
D  1 dayt 
D 1  " 
D 1  " 
D  2  " 
D  1  " 
D  2  " 
D  1  " 
SVirulence  control 
No serum  I  Dlday  I  I 
Serum absorbed 
with 
D 1 dayt 
D 1  " 
D 1  " 
D 1  " 
D  1  " 
D 1  " 
D2  " 
*t See Table V a for these footnotes. 
~; Additional  virulence  controls  showed  that  10  -1  through  10  -6  cc.  of  this 
culture killed mice. 
as  much  as  10  -I cc.  of  either  culture.  In  order, however,  to  detect 
quantitative differences in the protective value of the antisera, another 
test was made by injecting decreasing amounts of antiserum  together 
with  a  constant,  relatively large  dose of culture. 
Absorption  of  Protective  Antibodies:  Type  Ia  Antiserum.--Tables 
Va,  Vb,  Ve,  and Vd show the  results of such an experiment.  Other 
similar,  but  less  complete,  experiments  all  gave  consistent  results. 34  RELATED  TYPES  O]~  GROUP  B  HETJOLYTIC  STREPTOCOCCI 
For this experiment the same lots of antisera used in the precipitin 
absorption experiment recorded in Table III, were injected into mice 
in  dilutions  varying  from  1:1  to  1:30,000.  Simultaneously,  the 
animals  were  inoculated  intraperitoneally  with  0.5  cc.  of  a  1:200 
dilution of culture which had a  minimal lethal dose for mice of 10  -6 
to  10  -s cc.  Table Va shows the protective power of Type Ia anti- 
serum for mice infected with Type Ia organisms.  The high protective 
titer of the untreated serum for the homologous strain is recorded in 
column 3.  Mice which received this  serum survived infection even 
though  the  serum was  diluted  as  much as  1 part  in  2,S00.  With 
TABLE  VC 
Reciprocal Passive Protection Tests in Mice, Using Varying Amounts of A bsorbed and 
Unabsorbed Antiserum to Show That Types Ia and Ib Are Related but Not Identical 
Type Ia culture  (heterolo- 
gous)  strain  O 90 
O. 5 cc. 1: 200 dil. 
0.5 cc. sertml 
diluted 
1:1 
1:2 
1:10 
I:50 
1:100 
1:250 
1:500 
Type  Ib snfiserum (against  strain H  36  B) 
Serurn untreated 
S 
S 
S 
S 
D  1 day 
D 2 days 
D  1 day 
Serum absorbed 
with 
(heterologous) 
*Type Is 
D  1 dayt 
D  1  " 
D  1  " 
D  1  " 
D  1  " 
D  1  " 
D  1  " 
Serum  absorbed 
with 
(homologous) 
Type  I  b 
D  1 day  t 
D  1  " 
D  1  " 
D  i  " 
D  i  " 
D  1  " 
D  1  " 
Virulence controls recorded in Table V a. 
*t See Table Va for these footnotes. 
higher dilutions the deaths were irregular, but still the animals sur- 
vived for 2 to 3 days longer than the control mice, all of which died 
within  1  day.  The  animals  which  received  serum  absorbed  with 
bacteria of the homologous type all died within  1 day.  In further 
tests with larger amounts of this absorbed serum, it was found im- 
possible to protect mice against even one minimal lethal dose of the 
homologous  culture.  When,  on  the  other  hand,  the  serum  was 
absorbed with bacteria of the heterologous type, Ib,  the protective 
capacity of the absorbed  serum against  Type I a  infection was  not 
significantly reduced. REBECCA  C.  LANCEFIELD  35 
These  same  lots  of  Type  Ia  antisera  were  tested  simultaneously 
for protective action against the heterologous Type Ib strain, H  36 B, 
as  shown  in  Table Vb.  Here again,  the  untreated  serum  protected 
TABLE  vd 
Reciprocal Passive Protection  Tests  in Mice,  Using  Varying Amounts of Absorbed 
and Unabsorbed Antiserum to Show That Types Ia and Ib Are Related but 
Not Identical 
Type Ib  culture  (homolo- 
gous)  strain  H 36 B 
0.5 cc. 1:200 dil. 
0.5 cc. of serum 
diluted 
1:1 
1:2 
1:10 
1:50 
1:100 
1:250 
1:500 
1:1,000 
1:1,500 
1:2,000 
1:2,500 
1:3,000 
1:4,000 
1:5,000 
1:6,000 
1:7,000 
1:8,000 
1:9,000 
1:10,000 
1:15,000 
1:20,000 
1:25,000 
1:30,000 
Type Ib antiserum (against  strain H 35 B) 
Serum untr  e~.ted 
S 
S 
S 
S 
S 
S 
S 
S 
S 
S 
S 
S 
S 
S 
S 
S 
S 
S 
S 
D 3 days 
D 1 day 
D 1  " 
D 3 days 
Serum absorbed 
with 
(hetexologous) 
*Type Ia 
S 
s 
s 
s 
s 
s 
s 
s 
s 
s 
s 
S 
Serum absorbed 
with 
(homolosous) 
Type Ib 
Dlday 
D 1  " 
D I  " 
D 1  " 
D 1  " 
D 1  " 
D  1  " 
D  1  " 
Virulence  controls recorded in Table V b. 
* See Table Va for this footnote. 
in  high  dilution  even  against  the  heterologous  culture.  The  ap- 
parently  greater protective  value  of the  serum  for the  heterologous 
strain than for the homologous is probably of no significance because 
of  the  lower  virulence  of the  heterologous  strain.  Its virulence  for 36  RELATED  TYPES  O1~  GROUP  B  HEMOLYTIC  STREPTOCOCCI 
mice varied  on  different occasions from  a  minimal lethal  dose  of 
l0  -s  to  10  -7 cc.,  while that of strain  O  90  rarely fell below 10  -8 cc. 
Tested against the heterologous strain, H 36 B, the Type Ia antiserum 
absorbed with either Type Ia or Type Ib bacteria failed entirely to 
protect mice against infection with this strain. 
These  absorption  experiments demonstrate that  the  homologous 
Type  Ia  bacteria  remove from Type  Ia  antiserum the  antibodies 
which protect against either strain, while the heterologous Type Ib 
strain  removes  only  that  antibody  which  protects  against  itself. 
This  agrees with the  evidence afforded by  the precipitin reaction. 
Absorption  of Protective  Antibodies:  Type  Ib  Antiserum.--Tables 
Vc and Vd show the  results of similar experiments with Type Ib 
antiserum.  In Table Vc there are shown the results of passive pro- 
tection tests in  mice injected with absorbed and unabsorbed Type 
Ib antiserum and inoculated with the heterologous Type Ia strain, 
O 90.  This serum had a  relatively low titer of protective antibody 
for the heterologous strain, although it protected mice against infec- 
tion with the homologous strain, H  36 B, even when the serum was 
diluted 1 : 10,000 (cf. 3rd column of Table Vd).  Absorption with the 
homologous Type  Ib  strain  removed the  protective antibodies for 
both  Types Ia  and  Ib  (column 5,  Tables Vc and Vd),  in marked 
contrast to the absorbing capacity of the heterologous Type I a strain, 
which removed the antibody for itself only (column 4, Table Vc) and 
not that for the strain homologous to the serum (column 4,  Table 
Vd).  In this last titration the end-point for protection against  the 
homologous strain, H  36 B, was not reached, but obviously the pro- 
tective power of this lot of Type Ib serum absorbed with the heter- 
ologous Type I a strain was still high. 
DISCUSSION 
The results of the cross precipitin and cross protection tests with 
these reciprocally absorbed antisera and the control untreated anti- 
sera prove that one of the serological types previously identified within 
group B  streptococci really comprises two types, now designated as 
Types Ia and Ib.  ~  These are closely related, as shown convincingly 
by the large amount of cross protection with unabsorbed sera for the 
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as to give reciprocal protection, since, in each case, bacteria or extracts 
of  the  heterologous related  type  absorb  only  the  antibody  active 
against  its  own  type.  The  homologous type  organisms  or  their 
extracts, on the contrary, absorb all antibodies from a  given serum, 
including those for the heterologous related strains. 
The quantitative relationships are somewhat difficult of interpreta- 
tion,  since the relative  antibody  content of different antisera with 
respect to the two types varied considerably.  For example, serum, 
taken at an earlier date from the rabbit that furnished the Type Ia 
serum used in  the protection tests recorded in Tables Va and Vb, 
protected mice against both Types Ia and Ib when the serum was 
diluted 1: 100; while the same dilution (1: 100) of a Type Ia antiserum 
from another rabbit, immunized with the same strain, protected mice 
against infection with the homologous  Type I a organisms but afforded 
no protection against the heterologous Type Ib organisms.  Nor was 
it possible to detect any precipitation of this serum with extracts of 
the  heterologous Type  Ib  strain.  These  variable  responses of  in- 
dividual  animals  in  producing  antibodies  to  the  minor  antigenic 
groupings are in accord with the findings of Sugg and Neill (24a) with 
respect to cross reactions between yeast and Pneumococcus Type II, 
and of the same authors and their associates  (5,  6)  with regard to 
Types  III  and  VIII  strains of pneumococci.  Heidelberger, Kabat, 
and Shrivastava  (10)  also reported similar findings in their quanti- 
tative  studies of  the precipitin  reaction  with  Types III  and  VIII 
pneumococcus polysaccharides. 
The antigens under investigation in the present study were probably 
polysaccharides for a  study of the chemical properties of  the  type- 
specific  substance  of  a  Type  Ia  strain,  previously reported  (30b), 
showed that this substance is, in fact, a  polysaccharide; and incom- 
plete investigation of the type-specific substance of a Type Ib strain 
indicates the probability that this is also a polysaccharide. 
Although  the  cross  reactions  described  in  this  paper  might  be 
explained as due to the presence in both Types Ia and Ib of a common 
antigen, and in addition of a  separate type-specific antigen in each, 
the  available  evidence is  insufficient to  determine whether  this  is 
the case or whether the type-specific substances of the two types are 
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cross reactions.  The latter viewpoint is probably the more tenable, 
since in neither case has it been possible to separate the type-specific 
substance chemically into two fractions, one common to the two types 
and  one  strictly specific for the type in question, or into fractions of 
different reactivities.  Further study of these relationships is being 
made  by  growing each  organism in  media  containing respectively 
antisera for each of these related types.  The preliminary indications 
are that, under certain conditions, the Type Ib strain, H  36 B, can be 
made to produce an antigen which is almost strictly specific for that 
type, but the results with the Type Ia strain are somewhat different 
and too incomplete for inclusion in this report. 
The  foregoing observations are  of  interest  in  connection with  a 
number of experiments reported recently in which it has been found 
that,  although cross immunological reactions between bacterial and 
other  naturally  occurring  substances  usually  indicate  genetic  rela- 
tionships, as is true in the present instance, it also sometimes happens 
that  no  such  consistent relationship is  apparent.  However, where 
fairly complete chemical data are  available,  it has been found that 
serological similarities are always based on chemical likenesses whether 
the  determinant  substances  are  derived  from  related  or  from  un- 
related sources. 
A chemical  andimmunological  investigation of particular importance 
as a  pattern in determining the nature of such partial cross immune 
reactions  among bacteria,  was  the  formation of  effective  antigens 
from a  and fl glucosides by linking them to serum proteins (17 a, b). 
Avery,  Goebel,  and Babers were thereby enabled to furnish an ex- 
ample of substances of known structure which simulated the serolog- 
ical behavior of such bacterial polysaccharides as those derived from 
Friedlitnder's  bacillus  type  B,  and  Pneumococcus Type  II.  The 
only  difference in  the  two  synthetic  antigens  studied  was  in  the 
position of  the  glucoside linkages,  but  this  was  reflected  in  their 
serological  reactions.  Other  studies  which  show  a  chemical  basis 
for serological relationships have already been discussed, as well as 
the conclusions of several investigators that a  single complex chem- 
ical  substance  may induce the  formation in  animals of more than 
one antibody. 
With these facts in mind, it is not surprising to find another example REBECCA  C. LANCEFIELD  39 
of closely related but not identical antigenic substances in bacteria 
of the same  serological group.  Although the  chemical background 
has not been sufficiently developed to establish a  chemical basis for 
the observed immunological relationship between Types Ia and Ib, 
group  B  hemolytic streptococci,  it  seems probable  that  each  type 
is  characterized  by  a  specific  polysaccharide  which  is  chemically 
similar  to,  but  not  identical with,  the  type-specific  polysaccharide 
of the related type. 
SUMMARY 
1.  Among  group  B  hemolytic  streptococci  one  serological  type 
previously  described  as  homogencous has  been  shown,  instead,  to 
contain two  closely related types,  distinguishable by  reciprocal ab- 
sorption  experiments.  These  streptococci  arc  designated  Types 
Ia and Ib.  4 
2.  Homologous organisms in each case absorb all antibodies from 
their respective antisera, while organisms of the heterologous related 
type  absorb  only the  antibody  responsible  for  the  cross  reactions. 
Group  B  streptococci of other  types  do  not  absorb  the  antibodies 
responsible for the cross reactions between these two related types. 
The  precipitin  reaction  and  passive  protection  tests  in  mice  were 
employed in this analysis. 
3.  The  type-specific  substance  of  Type  Ia  is  a  polysaccharide. 
Preliminary study indicates that this is also true of Type Ib.  While 
no data are available concerning the chemical relationships of these 
substances, it seems probable that the two types elaborate  polysac- 
charides, related chemically as well as serologically. 
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